These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8589872)

  • 1. Increased propensity of women to develop torsades de pointes during complete heart block.
    Kawasaki R; Machado C; Reinoehl J; Fromm B; Baga JJ; Steinman RT; Lehmann MH
    J Cardiovasc Electrophysiol; 1995 Nov; 6(11):1032-8. PubMed ID: 8589872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes.
    Kurita T; Ohe T; Marui N; Aihara N; Takaki H; Kamakura S; Matsuhisa M; Shimomura K
    Am J Cardiol; 1992 Mar; 69(6):628-33. PubMed ID: 1536113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repolarization characteristics and incidence of Torsades de Pointes in patients with acquired complete atrioventricular block.
    Bozkaya YT; Eroğlu Z; Kayikçioğlu M; Payzin S; Can LH; Kültürsay H; Hasdemir C
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():98-100. PubMed ID: 17584695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
    Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
    Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes.
    Brady WJ; DeBehnke DJ; Laundrie D
    Acad Emerg Med; 1999 Jun; 6(6):609-17. PubMed ID: 10386678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
    Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
    Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionic mechanisms of acquired QT prolongation and torsades de pointes in rabbits with chronic complete atrioventricular block.
    Tsuji Y; Opthof T; Yasui K; Inden Y; Takemura H; Niwa N; Lu Z; Lee JK; Honjo H; Kamiya K; Kodama I
    Circulation; 2002 Oct; 106(15):2012-8. PubMed ID: 12370228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the onset of torsade de pointes arrhythmias in the acquired long QT syndrome.
    Vos MA; Gorenek B; Verduyn SC; van der Hulst FF; Leunissen JD; Dohmen L; Wellens HJ
    Cardiovasc Res; 2000 Dec; 48(3):421-9. PubMed ID: 11090837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
    Darbar D; Kimbrough J; Jawaid A; McCray R; Ritchie MD; Roden DM
    J Am Coll Cardiol; 2008 Feb; 51(8):836-42. PubMed ID: 18294569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT prolongation and torsades de pointes in a patient with heart block and a pacemaker.
    Bernstein BS; Silver ES; Liberman L
    Cardiol Young; 2016 Jan; 26(1):161-3. PubMed ID: 25599745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
    Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
    Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Torsades de pointes" and atrioventricular block.
    Moroe K; Saku K; Tashiro N; Hiroki T; Arakawa K
    Clin Cardiol; 1988 Jan; 11(1):9-13. PubMed ID: 3349663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
    Lazzerini PE; Laghi-Pasini F; Bertolozzi I; Morozzi G; Lorenzini S; Simpatico A; Selvi E; Bacarelli MR; Finizola F; Vanni F; Lazaro D; Aromolaran A; El Sherif N; Boutjdir M; Capecchi PL
    Heart; 2017 Nov; 103(22):1821-1829. PubMed ID: 28490617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
    Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
    Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.